A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Dr. Sevigny joins Rapport following his tenure as chief medical officer at Prevail Therapeutics See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze ...

Eli Lilly has acquired Prevail, a biotech focusing on gene therapies for neurodegenerative diseases including Parkinson's, in a deal potentially worth more than $1 billion. The big US pharma is to ...

The Medtronic Prevail drug coated balloon [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced results from a ...